Fort, L.P. Innoviva, Inc. Transaction History

Fort, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$8.11 - $15.23 $46,267 - $86,887	-5,705 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$10.28 - $14.38 $58,195 - $81,405	-5,661 Reduced 49.81%	5,705 $81,000
Q3 2019 Nov 13, 2019	BUY	$10.05 - $14.55 $371 - $538	37 Added 0.33%	11,366 $120,000
Q2 2019 Aug 13, 2019	BUY	$13.1 - $14.95 $10,899 - $12,438	832 Added 7.93%	11,329 $165,000
Q1 2019 May 14, 2019	BUY	$13.69 - $20.06 $73,173 - $107,220	5,345 Added 103.75%	10,497 $147,000
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $71,921 - $94,075	5,152 New	5,152 $90,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.